Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc...
Winston Pharmaceuticals reported revenue of $1.39 million for fiscal year 2009, up 208.2% from fiscal year 2008, and net income of -$2.66 million. In Q1 2010 (the quarter ended March 31, 2010) revenue was $316,706, down 6.8% from a year before.
Figures from company filings; latest fiscal year ended December 31, 2009.
No profile data available.